Mac-2 binding protein and galectin-3 expression in mucinous tumours of the ovary

An annealing control primer system and immunohistochemical study

Ju-Han Lee, Xianglan Zhang, Bong Kyung Shin, Eung Seok Lee, Insun Kim

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Aim:We used a new differential display method, the annealing control primer ACP system, to analyse the differentially expressed genes in mucinous ovarian tumours. To verify the corresponding target gene, immunohistochemical staining was performed on various epithelial tumours of the ovary. Methods and Results: The ACP-based reverse transcriptase-polymerase chain reaction revealed that 21 genes were upregulated in the mucinous ovarian adenoma and 14 genes were upregulated in the mucinous ovarian carcinoma. Among them, we selected one upregulated gene, the Mac-2 binding protein Mac-2 BP, and verified the expression of the Mac-2 BP and its ligand, galectin-3, in a variety of epithelial ovarian tumours by immunohistochemistry. Positive expression of the Mac-2 BP was significantly higher in the mucinous ovarian tumours compared to the other epithelial tumours. Mac-2 BP expression was significantly increased in the borderline and malignant tumours compared to the benign tumours. Galectin-3 expression was more frequent in clear cell carcinomas, serous tumours and mucinous tumours than in endometrioid and transitional tumours. However, there were no differences in galectin-3 expression in comparisons among benign, borderline and malignant mucinous and serous tumours. Conclusion: These data indicate that the Mac-2 BP may play a role in the development and progression of mucinous ovarian tumours.

Original languageEnglish
Pages (from-to)229-233
Number of pages5
JournalPathology
Volume41
Issue number3
DOIs
Publication statusPublished - 2009 Jan 1

Fingerprint

Galectin 3
Ovary
Carrier Proteins
Neoplasms
Genes
Mucinous Adenocarcinoma
Reverse Transcriptase Polymerase Chain Reaction
Adenoma

Keywords

  • Galectin-3
  • Mac-2 binding protein
  • Mucinous tumour
  • Ovary

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

@article{d8944c3eeaa14209ac9d99f39a90ceb0,
title = "Mac-2 binding protein and galectin-3 expression in mucinous tumours of the ovary: An annealing control primer system and immunohistochemical study",
abstract = "Aim:We used a new differential display method, the annealing control primer ACP system, to analyse the differentially expressed genes in mucinous ovarian tumours. To verify the corresponding target gene, immunohistochemical staining was performed on various epithelial tumours of the ovary. Methods and Results: The ACP-based reverse transcriptase-polymerase chain reaction revealed that 21 genes were upregulated in the mucinous ovarian adenoma and 14 genes were upregulated in the mucinous ovarian carcinoma. Among them, we selected one upregulated gene, the Mac-2 binding protein Mac-2 BP, and verified the expression of the Mac-2 BP and its ligand, galectin-3, in a variety of epithelial ovarian tumours by immunohistochemistry. Positive expression of the Mac-2 BP was significantly higher in the mucinous ovarian tumours compared to the other epithelial tumours. Mac-2 BP expression was significantly increased in the borderline and malignant tumours compared to the benign tumours. Galectin-3 expression was more frequent in clear cell carcinomas, serous tumours and mucinous tumours than in endometrioid and transitional tumours. However, there were no differences in galectin-3 expression in comparisons among benign, borderline and malignant mucinous and serous tumours. Conclusion: These data indicate that the Mac-2 BP may play a role in the development and progression of mucinous ovarian tumours.",
keywords = "Galectin-3, Mac-2 binding protein, Mucinous tumour, Ovary",
author = "Ju-Han Lee and Xianglan Zhang and Shin, {Bong Kyung} and Lee, {Eung Seok} and Insun Kim",
year = "2009",
month = "1",
day = "1",
doi = "10.1080/00313020902756279",
language = "English",
volume = "41",
pages = "229--233",
journal = "Pathology",
issn = "0031-3025",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Mac-2 binding protein and galectin-3 expression in mucinous tumours of the ovary

T2 - An annealing control primer system and immunohistochemical study

AU - Lee, Ju-Han

AU - Zhang, Xianglan

AU - Shin, Bong Kyung

AU - Lee, Eung Seok

AU - Kim, Insun

PY - 2009/1/1

Y1 - 2009/1/1

N2 - Aim:We used a new differential display method, the annealing control primer ACP system, to analyse the differentially expressed genes in mucinous ovarian tumours. To verify the corresponding target gene, immunohistochemical staining was performed on various epithelial tumours of the ovary. Methods and Results: The ACP-based reverse transcriptase-polymerase chain reaction revealed that 21 genes were upregulated in the mucinous ovarian adenoma and 14 genes were upregulated in the mucinous ovarian carcinoma. Among them, we selected one upregulated gene, the Mac-2 binding protein Mac-2 BP, and verified the expression of the Mac-2 BP and its ligand, galectin-3, in a variety of epithelial ovarian tumours by immunohistochemistry. Positive expression of the Mac-2 BP was significantly higher in the mucinous ovarian tumours compared to the other epithelial tumours. Mac-2 BP expression was significantly increased in the borderline and malignant tumours compared to the benign tumours. Galectin-3 expression was more frequent in clear cell carcinomas, serous tumours and mucinous tumours than in endometrioid and transitional tumours. However, there were no differences in galectin-3 expression in comparisons among benign, borderline and malignant mucinous and serous tumours. Conclusion: These data indicate that the Mac-2 BP may play a role in the development and progression of mucinous ovarian tumours.

AB - Aim:We used a new differential display method, the annealing control primer ACP system, to analyse the differentially expressed genes in mucinous ovarian tumours. To verify the corresponding target gene, immunohistochemical staining was performed on various epithelial tumours of the ovary. Methods and Results: The ACP-based reverse transcriptase-polymerase chain reaction revealed that 21 genes were upregulated in the mucinous ovarian adenoma and 14 genes were upregulated in the mucinous ovarian carcinoma. Among them, we selected one upregulated gene, the Mac-2 binding protein Mac-2 BP, and verified the expression of the Mac-2 BP and its ligand, galectin-3, in a variety of epithelial ovarian tumours by immunohistochemistry. Positive expression of the Mac-2 BP was significantly higher in the mucinous ovarian tumours compared to the other epithelial tumours. Mac-2 BP expression was significantly increased in the borderline and malignant tumours compared to the benign tumours. Galectin-3 expression was more frequent in clear cell carcinomas, serous tumours and mucinous tumours than in endometrioid and transitional tumours. However, there were no differences in galectin-3 expression in comparisons among benign, borderline and malignant mucinous and serous tumours. Conclusion: These data indicate that the Mac-2 BP may play a role in the development and progression of mucinous ovarian tumours.

KW - Galectin-3

KW - Mac-2 binding protein

KW - Mucinous tumour

KW - Ovary

UR - http://www.scopus.com/inward/record.url?scp=68849101942&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=68849101942&partnerID=8YFLogxK

U2 - 10.1080/00313020902756279

DO - 10.1080/00313020902756279

M3 - Article

VL - 41

SP - 229

EP - 233

JO - Pathology

JF - Pathology

SN - 0031-3025

IS - 3

ER -